Butcher Arthur C's Form 4 filing
Boston Scientific CorpBSX · filed May 5, 2025
- Accession no.
- 0001225208-25-004716
- Filed
- May 5, 2025
- Trade date
- May 1, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.77M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butcher Arthur CCIK 0001678249 | Officer (EVP& Grp Pres, MedSurg & APAC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Common Stock | MOption exerciseAcquired | +6,952 | $27.09 | +$188,329.68 | 29,187 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseAcquired | +6,176 | $24.55 | +$151,620.8 | 35,363 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseAcquired | +3,177 | $22.71 | +$72,149.67 | 38,540 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseAcquired | +1,009 | $17.26 | +$17,415.34 | 39,549 | Direct | |
| May 1, 2025 | Common Stock | SSaleDisposed | −17,314 | $102.06F2 | −$1,767,066.84 | 22,235 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Common Stock | MOption exerciseDisposed | −6,952 | $0.00 | $0 | 13,904 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseDisposed | −1,009 | $0.00 | $0 | 2,018 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseDisposed | −6,176 | $0.00 | $0 | 12,351 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseDisposed | −3,177 | $0.00 | $0 | 6,353 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.535 to $102.52, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.